The list below includes the top three compensation packages of $1 million or more at each nonprofit, and is based on CharityWatch’s most current information as of April 25th, 2024.
The Compensation column includes total of base compensation, bonus and incentive compensation, retirement and deferred compensation, nontaxable benefits, and other reportable compensation as reported to the IRS (Form W-2, 1099-MISC, and/or 1099-NEC), excluding any amounts already reported by the organization in a prior year IRS Form 990. Retirement payouts, deferred compensation, severance, and bonuses that (a) comprise 75% or more of total annual compensation, or (b) total to $1 million or more are footnoted.
NOTE: Due to differences in the way compensation might be allocated, high salaries do not necessarily indicate inefficiencies just as low salaries are not always beneficial. A more detailed explanation is provided below the chart.
| Name & Title | Charity | Compensation | Fiscal Year | |
|---|---|---|---|---|
| Craig B. Thompson, M.D. Past President/CEO |
Memorial Sloan Kettering Cancer Center | $8,104,960 | 12/31/2022 | |
| Note: Includes $6,080,000 bonus & incentive compensation. | ||||
| Jason Klein Senior VP/Chief Investment Officer |
Memorial Sloan Kettering Cancer Center | $6,868,047 | 12/31/2022 | |
| Note: Includes $2,530,000 bonus & incentive compensation and $2,980,253 deferred compensation. | ||||
| Nancy Brown CEO |
American Heart Association | $4,145,055 | 06/30/2023 | |
| Note: Includes $2,994,278 bonus & incentive compensation. | ||||
| Robert W. Stone President/CEO |
City of Hope & Affiliates | $3,684,871 | 09/30/2022 | |
| Note: Includes $1,445,927 bonus & incentive compensation. | ||||
| Mark Bilsky, M.D. Attenting – Neurosurgery |
Memorial Sloan Kettering Cancer Center | $3,403,996 | 12/31/2022 | |
| Note: Includes $1,500,000 bonus & incentive compensation. | ||||
| Ellen Raney, M.D. Orthopedic Surgeon/Professor |
Shriners Hospitals for Children | $3,366,552 | 12/31/2022 | |
| Note: Includes $2,664,737 defined benefit supplemental executive retirement plan payment. | ||||
| Laurie H. Glimcher, M.D. President/CEO |
Dana-Farber Cancer Institute | $2,802,980 | 09/30/2022 | |
| Jack Mahler, M.D. Chief Investment Officer |
Cystic Fibrosis Foundation | $2,248,532 | 12/31/2022 | |
| Note: Includes $1,760,233 bonus & incentive compensation. | ||||
| Harlan Levine, M.D. President, Health Innovation & Policy |
City of Hope & Affiliates | $2,232,377 | 09/30/2022 | |
| Michael S. Salem, M.D. President/CEO |
National Jewish Health | $2,020,146 | 06/30/2022 | |
| Steven T. Rosen, M.D. Chief Scientific Officer |
City of Hope & Affiliates | $1,955,873 | 09/30/2022 | |
| Myra Biblowit President/CEO |
Breast Cancer Research Foundation | $1,837,111 | 06/30/2022 | |
| David Ellison Chair, Pathology/Director, Neuropathology |
St. Jude Children’s Research Hospital | $1,829,593 | 06/30/2022 | |
| Note: Includes $1,035,264 non-qualified deferred compensation plan payment. | ||||
| Emily Naus, M.D. Past Anesthesiologist |
Shriners Hospitals for Children | $1,547,530 | 12/31/2022 | |
| Note: Includes $1,005,253 defined benefit supplemental executive retirement plan payment. | ||||
| James R. Downing President/CEO |
St. Jude Children’s Research Hospital | $1,546,372 | 06/30/2022 | |
| Harry Johns Past President/CEO |
Alzheimer’s Association | $1,468,134 | 06/30/2022 | |
| Deborah W. Brooks Co-Founder/CEO |
Michael J. Fox Foundation for Parkinson’s Research | $1,423,665 | 12/31/2022 | |
| Edward J. Benz, Jr., M.D. President/CEO Emeritus |
Dana-Farber Cancer Institute | $1,396,571 | 09/30/2022 | |
| Kelli Jo Shidler, M.D. Physician |
Boys Town | $1,350,715 | 12/31/2022 | |
| Maureen Maciel, M.D. Past Chief of Staff |
Shriners Hospitals for Children | $1,334,258 | 12/31/2022 | |
| Todd Sherer Chief Mission Officer |
Michael J. Fox Foundation for Parkinson’s Research | $1,310,814 | 12/31/2022 | |
| David M. Yarnold Past President/CEO |
National Audubon Society | $1,276,173 | 06/30/2022 | |
| Charles Ryan, M.D. President/CEO |
Prostate Cancer Foundation | $1,248,911 | 12/31/2022 | |
| Cristian Samper President/CEO |
Wildlife Conservation Society | $1,237,933 | 06/30/2022 | |
| Thomas E. Merchant Chair, Radiation Oncology |
St. Jude Children’s Research Hospital | $1,232,030 | 06/30/2022 | |
| Marc H. Morial President/CEO |
National Urban League (National Office) | $1,208,640 | 12/31/2022 | |
| Jonathan A. Greenblatt CEO/National Director |
Anti-Defamation League & Foundation | $1,207,978 | 12/31/2022 | |
| Michael P. Boyle, M.D. President/CEO |
Cystic Fibrosis Foundation | $1,190,095 | 12/31/2022 | |
| Leslie Upton COO |
American Heart Association | $1,187,544 | 06/30/2023 | |
| Sarah C. Hirshland CEO |
United States Olympic & Paralympic Committee | $1,175,947 | 12/31/2022 | |
| John Allen Past President |
Brookings Institution | $1,172,263 | 06/30/2022 | |
| James L. Clark President/CEO |
Boys & Girls Clubs of America (National Office) | $1,171,813 | 12/31/2022 | |
| Wayne R. LaPierre Past Executive VP & NRA Foundation Ex-Officio |
National Rifle Association (NRA) | $1,171,699 | 12/31/2022 | |
| Note: Wayne LaPierre announced his resignation as chief executive of the NRA, effective January 31, 2024. | ||||
| Carter Roberts President/CEO |
World Wildlife Fund | $1,160,844 | 06/30/2022 | |
| Michael L. Lomax President/CEO |
UNCF/United Negro College Fund | $1,149,543 | 03/31/2022 | |
| David Miliband President/CEO |
International Rescue Committee | $1,142,414 | 09/30/2022 | |
| Mariell Jessup Chief Science & Medical Officer |
American Heart Association | $1,131,559 | 06/30/2023 | |
| Earl Lee Managing Director, Investments |
Cystic Fibrosis Foundation | $1,130,430 | 12/31/2022 | |
| Karen E. Knudsen CEO |
American Cancer Society | $1,118,608 | 12/31/2022 | |
| Matt Bershadker President/CEO |
American Society for the Prevention of Cruelty to Animals (ASPCA) | $1,117,171 | 12/31/2022 | |
| Saro Jahani President/CEO |
HelpMeSee | $1,023,399 | 12/31/2022 | |
CharityWatch’s “A+” to “F” letter grade ratings and financial efficiency ratios take into account how a nonprofit’s employee salaries and other compensation are allocated among program, management & general, and fundraising functions.
Nonprofits generally allocate compensation based on how each member of staff spends their time. For example, the salary of a doctor who spends 100% of their time on a charity’s program activities, such as providing direct medical care, would generally be allocated 100% to program. A fundraising or development executive’s salary would be allocated 100% to fundraising. An executive director or president of a charity might spent 40% of their time on program activities, 25% of their time managing their nonprofit, and 35% on fundraising, and this person’s compensation would be allocated among program, management & general, and fundraising expenses commensurately.
Due to differences in the way compensation is allocated by charities in their IRS Form(s) 990 and audited financial statements, high salaries do not necessarily indicate inefficiencies just as low salaries are not always beneficial. Rather than perceiving a particular nonprofit executive’s compensation as too high or too low based on its nominal value, appropriate salaries are better determined by considering factors such as special skills needed for the position, relevant education and experience, and the complexity of a charity’s operations. CharityWatch encourages donors to view each nonprofit’s letter grade rating to better understand how efficiently it is operating overall prior to making a giving decision.
This information was made possible by contributions from donors like you. As the only charity watchdog in the United States, CharityWatch relies on public support to fund our work with journalists, our research into wrongdoing in the nonprofit sector, and our charity ratings. Your donations are noticed, needed, and greatly appreciated.
Will you help CharityWatch fight the good fight by making a donation today?
Thanks for your help!
P.S. Sign up for our bi-weekly email newsletter and subscribe to our YouTube Channel here.